Join the SmallCapReview mailing list.

AUPH Aurinia Pharmaceuticals: A late-stage biopharmaceutical company providing novel products specifically engineered to treat a limited, targeted patient population suffering from serious disease states for which there is a high unmet medical need.  More.
MYGN Myriad Genetics: A  personalized medicine company, that focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. MYGN has a collaboration with AstraZeneca for the development of an indication for BRACAnalysis CDx. More.     
ICPT Intercept Pharmaceuticals: A biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat orphan and more prevalent liver diseases utilizing its expertise in bile acid chemistry.  OCA has received orphan drug designation in both the United States and Europe for the treatment of PBC. More.                 

Best Small Caps By Share Price Growth

Where Small Caps Are Less Risky

Cup With Handle Chart Pattern

Meaning Of The Fifth Letter Of Nasdaq Ticker Symbols

Aurinia Announces Acceptance of Voclosporin Late-Breaking Presentation at the National Kidney Foundation 2017 Spring Clinical Meetings

Volume Leaders
52 Week Highs/Lows
Small-Cap Index
Check Futures Here
Level II Quotes
Stock Screener
Performance by Industry
After Hours Market
World Markets


Visit Our Resources Page

Past Articles Worth Reading












 Where Small Cap Stocks Thrive Since 1999                                           

2017: Year Of The Small Cap Stock

7 Small Caps With Big Dividends...

Aurinia Highlights 48-Week Data from Open-Label AURION Study at 12th International Congress on SLE (LUPUS 2017)...AUPH

5 Beaten Down Value Stocks...

10 Small Cap Stocks That Could Double In The Next Three Months...

Where Small Caps Are Working...

Define Small Cap Stock... Market Cap between $250 million and $1 billion.

Aurinia Closes US$173.1 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common...(AUPH)

Myriad Genetics Announces Five Scientific Presentations at the 2017 American College of Medical Genetics Annual Clinical Genetics Meeting...(MYGN)

Why Now Is A Good Time To Own Small Cap Banks...

Rate Hike Creates New Opportunity In Small Caps...  

Small Cap Tick Pilot Program Disappointing... We seen this coming from a mile away.

Aurinia Pharmaceuticals (AUPH)



"Voclosporin has the potential to become a best in class medication and the first approved treatment for LN in the U.S. and Europe."

More on AUPH here...

Myriad Genetics (MYGN)


"Myriad has the deepest diagnostic pipeline across the disease spectrum."

More on MYGN here...

Intercept Pharmaceuticals (ICPT)


"A Biopharmaceutical Company Focused On The Development And Commercialization Of Novel Therapeutics To Treat Chronic Liver Diseases."

More on ICPT here...

Follow Us On


Small Cap Biotechs Gain Steam As Cutting Regulations Are On The Table

5 Small Cap Biotechs For March

3 Small Cap Stocks For Years of High Returns

10 High Yield Small Cap Dividend Stocks For 2017

MYGN's BRACAnalysis CDx® Test Successfully Identified Metastatic Breast Cancer Patients with Improved Outcomes from AstraZeneca's...(MYGN)

The Next Leg Of The Small Cap Rally Starts Now

The Long And Short Of Small Cap Options

Microcap Stocks - There's A Lot To Like About Them

Compelling Reasons To Keep Small Caps

4 Small Caps To Look At

Small Cap Stocks And Emerging Markets Ripe For Growth

Small Cap Defense

Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints, Achieving Highest Complete Remission Rate of Any Global Lupus

Bank Rally Likely To Shift To Microcap Banks

Why Do Alpha Seekers Find It In Small Caps?

MYGN's Prolaris® Test Significantly Improves the Risk Classification for One Third of Men Diagnosed with Localized Prostate Cancer...(MYGN)

MYGN Joins Small Cap 600

A Most Wonderful Year For Small Caps

Why Small Caps Remain Some Of The Top Stocks To Invest In

Small Cap Stocks - Time For Active Investing

5 Small Cap Picks

5 Charts: Small Caps With A Bull Flag

Small Cap ETFs For A New Era

Subscribers to our Free newsletter will receive stock reports and news alerts for small-cap stocks via email. You can sign-up here.


"A Primer In Small Cap Investing"® is a leading destination for small-cap picks and news. The Purpose of is to profile and bring awareness to companies with a market cap of less than $1 billion, these small-cap stocks will primarily trade on the Nasdaq Small-Cap market. We also issue daily small cap stocks to watch via various newswires. We will strive to bring you the undiscovered, the undervalued, and the oversold. does not give "buy" recommendations, price targets nor suggest entry and exit points.

"A Look at Small Cap Stocks that may no longer be Small Caps"




© 1999-2017 Any questions or comments regarding this site should be directed to